Fintel reports that on February 24, 2025, Oppenheimer upgraded their outlook for BioMarin Pharmaceutical (NasdaqGS:BMRN) from ...

The women filed the lawsuit last Friday against the Milwaukee Bucks, former Bucks guard Patrick Beverley and assistant coach ...

Efforts are ongoing to rehabilitate the Oppenheimer Beach Facility on the island of St. John thanks to a $1 million grant ...

Oppenheimer upgraded BioMarin (BMRN) to Outperform from Perform with a $98 price target BioMarin reported strong Q4 results and Oppenheimer ...

Patrick Beverley and the Milwaukee Bucks are reportedly facing legal action over an incident that occurred during the 2024 ...

As NVIDIA increases the output of its next-generation Blackwell architecture, its AI hardwareespecially its H200 GPUsis ...

Nvidia (NASDAQ:NVDA) is ready to turn the page on the DeepSeek drama and shift focus to its next big catalyst. The AI chip giant is set to ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Toll Brothers (NYSE:TOL – Free Report) had its price objective cut by Oppenheimer from $189.00 to $165.00 in a research note ...

Rupesh Parikh, Oppenheimer managing director and senior analyst, joins 'Squawk Box' to break down Walmart's quarterly ...

Nvidia is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI chipmaker's stock.

Performant Healthcare, Inc. (Nasdaq: PHLT) (“Performant”), a leading provider of technology-enabled payment integrity, ...